Maxwell Finland, MD - Publications

Affiliations: 
Harvard University, Cambridge, MA, United States 
Area:
Epidemiology, antibiotics, pneumonia, Staphylococcus
Website:
http://en.wikipedia.org/wiki/Maxwell_Finland

248 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Finland M. Antibiotic-resistant micrococcic infections. Jama. 312: 1475. PMID 25291597 DOI: 10.1001/Jama.2013.279776  0.367
2010 Finland M. IMMUNOLOGICAL REACTIONS OF PNEUMONIC PLEURAL FLUIDS. The Journal of Experimental Medicine. 55: 169-79. PMID 19869983 DOI: 10.1084/Jem.55.2.169  0.306
2010 Finland M, Sutliff WD. SPECIFIC CUTANEOUS REACTIONS AND CIRCULATING ANTIBODIES IN THE COURSE OF LOBAR PNEUMONIA : I. CASES RECEIVING NO SERUM THERAPY. The Journal of Experimental Medicine. 54: 637-52. PMID 19869947 DOI: 10.1084/Jem.54.5.637  0.302
2002 Kass EH, Finland M. Asymptomatic infections of the urinary tract. The Journal of Urology. 168: 420-4. PMID 12131280  0.478
2002 Kass EH, Finland M. Asymptomatic Infections of the Urinary Tract * Journal of Urology. 168: 420-424. DOI: 10.1016/S0022-5347(05)64650-2  0.536
1983 Finland M. Empiric therapy for bacterial infections: the historical perspective. Reviews of Infectious Diseases. 5: S2-8. PMID 6342095 DOI: 10.1093/Clinids/5.Supplement_1.S2  0.343
1982 Finland M, Kass EH, Platt R. Summary of the Symposium Clinical Infectious Diseases. 4: 185-195. DOI: 10.1093/Clinids/4.2.185  0.448
1979 Finland M. Emergence of antibiotic resistance in hospitals, 1935-1975. Reviews of Infectious Diseases. 1: 4-22. PMID 45521 DOI: 10.1093/Clinids/1.1.4  0.345
1978 Finland M, Barnes MW. Duration of hospitalization for bacteremic infections at Boston City Hospital during 12 selected years between 1935 and 1972. The Journal of Infectious Diseases. 138: 837-48. PMID 368265 DOI: 10.1093/Infdis/138.6.837  0.302
1978 Finland M. And the walls come tumbling down. More antibiotic resistance, and now the pneumococcus. The New England Journal of Medicine. 299: 770-1. PMID 29220 DOI: 10.1056/Nejm197810052991408  0.382
1978 Finland M, Barnes MW. Changing ecology of acute bacterial empyema: occurrence and mortality at Boston City Hospital during 12 selected years from 1935 to 1972. The Journal of Infectious Diseases. 137: 274-91. PMID 24669 DOI: 10.1093/Infdis/137.3.274  0.341
1977 Finland M, Barnes MW. Duration of hospitalization for acute bacterial meningitis at Boston City Hospital during 12 selected years, 1935-1972. The American Journal of the Medical Sciences. 274: 4-12. PMID 900154 DOI: 10.1097/00000441-197707000-00001  0.316
1977 Sackel SG, Alpert S, Rosner B, McCormack WM, Finland M. In vitro activity of p-hydroxybenzyl penicillin (penicillin X) and five other penicillins against Neisseria gonorrhoeae: comparisons of strains from patients with uncomplicated infections and from women with pelvic inflammatory disease. Antimicrobial Agents and Chemotherapy. 12: 31-6. PMID 407840 DOI: 10.1128/Aac.12.1.31  0.309
1977 Finland M. Nosocomial epidemics seriatim. Multidrug-resistant bacteria and R factors. Archives of Internal Medicine. 137: 585-7. PMID 324422 DOI: 10.1001/Archinte.1977.03630170017007  0.378
1977 Finland M, Barnes MW. Acute bacterial meningitis at Boston City Hospital during 12 selected years, 1935-1972. The Journal of Infectious Diseases. 136: 400-15. PMID 20479 DOI: 10.1093/Infdis/136.3.400  0.318
1976 Baltimore RS, Klein JO, Wilcox C, Finland M. Synergy of mecillinam (FL1060) with penicillins and cephalosporins against Proteus and Klebsiella, with observations on combinations with other antibiotics and against other bacterial species. Antimicrobial Agents and Chemotherapy. 9: 701-5. PMID 1267442 DOI: 10.1128/Aac.9.4.701  0.322
1976 Finland M, Barnes MW. Changing etiology of bacterial infections. Antibiotics and Chemotherapy. 21: 170-5. PMID 1259364 DOI: 10.1159/000398533  0.334
1976 Finland M, McGowan JE. Nosocomial infections in surgical patients. Observations on effects of prophylactic antibiotics. Archives of Surgery (Chicago, Ill. : 1960). 111: 143-5. PMID 1252119 DOI: 10.1001/Archsurg.1976.01360200049008  0.348
1976 Sabath LD, Garner C, Wilcox C, Finland M. Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics. Antimicrobial Agents and Chemotherapy. 9: 962-9. PMID 938025 DOI: 10.1128/Aac.9.6.962  0.327
1976 Finland M, Garner C, Wilcox C, Sabath LD. Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics. The Journal of Infectious Diseases. 134: S297-307. PMID 825588 DOI: 10.1093/Infdis/135.Supplement_2.S297  0.335
1976 Finland M, Garner C, Wilcox C, Sabath LD. Susceptibility of "enterobacteria" to aminoglycoside antibiotics: comparisons with tetracyclines, polymyxins, chloramphenicol, and spectinomycin. The Journal of Infectious Diseases. 134: S57-74. PMID 184213 DOI: 10.1093/Infdis/134.Supplement_1.S57  0.31
1976 Finland M, Garner C, Wilcox C, Sabath LD. Susceptibility of beta-hemolytic streptococci to 65 antibacterial agents. Antimicrobial Agents and Chemotherapy. 9: 11-9. PMID 176926 DOI: 10.1128/Aac.9.1.11  0.306
1976 McCormack WM, Finland M. Drugs five years later. Spectinomycin. Annals of Internal Medicine. 84: 712-6. PMID 132888 DOI: 10.7326/0003-4819-84-6-712  0.364
1976 Finland M, Garner C, Wilcox C, Sabath LD. Susceptibility of pneumococci and Haemophilus influenzae to antibacterial agents. Antimicrobial Agents and Chemotherapy. 9: 274-87. PMID 5052 DOI: 10.1128/Aac.9.2.274  0.351
1975 Sabath LD, Garner C, Wilcox C, Finland M. Effect of inoculum and of beta-lactamase on the anti-staphylococcal activity of thirteen penicillins and cephalosporins. Antimicrobial Agents and Chemotherapy. 8: 344-9. PMID 1167043 DOI: 10.1128/Aac.8.3.344  0.312
1975 McGowan JE, Barnes MW, Finland M. Bacteremia at Boston City Hospital: Occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital-acquired cases. The Journal of Infectious Diseases. 132: 316-35. PMID 1159333 DOI: 10.1093/Infdis/132.3.316  0.326
1974 McGowan JE, Finland M. Usage of antibiotics in a general hospital: effect of requiring justification. The Journal of Infectious Diseases. 130: 165-8. PMID 4842338 DOI: 10.1093/Infdis/130.2.165  0.334
1974 McGowan JE, Finland M. Infection and antibiotic usage at Boston City Hospital: changes in prevalence during the decade 1964-1973. The Journal of Infectious Diseases. 129: 421-8. PMID 4544686 DOI: 10.1093/Infdis/129.4.421  0.36
1974 Finland M. Letter: Antibiotic-supplemented feeds. Jama. 229: 1723-4. PMID 4479159 DOI: 10.1001/Jama.1974.03230510015010  0.335
1974 Finland M, Barnes MW. Salmonellosis and shigellosis at Boston City Hospital. 1. Relationship to bacteremic infections due to enterobacteria. Jama. 229: 1183-6. PMID 4407932 DOI: 10.1001/Jama.1974.03230470025018  0.355
1974 Finland M, Garner C, Wilcox C, Sabath LD. Salmonellosis and shigellosis at Boston City Hospital. 2. Susceptibility of strains of Salmonellae and Shigellae to antibacterial agents. Jama. 229: 1309-12. PMID 4369157 DOI: 10.1001/Jama.1974.03230480025023  0.309
1974 McGowan JE, Garner C, Wilcox C, Finland M. Antibiotic susceptibility of gram-negative bacilli isolated from blood cultures. Results of tests with 35 agents and strains from 169 patients at Boston City Hospital during 1972. The American Journal of Medicine. 57: 225-38. PMID 4210609 DOI: 10.1016/0002-9343(74)90447-1  0.322
1974 Finland M, McGowan JE, Garner C, Wilcox C. Amoxicillin: in vitro susceptibility of "blood culture strains" of gram-negative bacilli and comparisons with penicillin G ampicillin, and carbenicillin. The Journal of Infectious Diseases. 129: suppl:S132-8. PMID 4210005 DOI: 10.1093/Infdis/129.Supplement_2.S132  0.309
1973 Finland M, Kass EH. Trimethoprim-sulfamethoxazole. Summary and comments on the conference. The Journal of Infectious Diseases. 128: Suppl:792-816. PMID 4758061 DOI: 10.1093/Infdis/128.Supplement_3.S792  0.491
1973 Bach MC, Sabath LD, Finland M. Susceptibility of Nocardia asteroides to 45 antimicrobial agents in vitro. Antimicrobial Agents and Chemotherapy. 3: 1-8. PMID 4597708 DOI: 10.1128/Aac.3.1.1  0.31
1973 Bach MC, Monaco AP, Finland M. Pulmonary nocardiosis. Therapy with minocycline and with erythromycin plus ampicillin. Jama. 224: 1378-81. PMID 4574377 DOI: 10.1001/Jama.224.10.1378  0.306
1973 Sabath LD, Wilcox C, Garner C, Finland M. In vitro activity of cefazolin against recent clinical bacterial isolates. The Journal of Infectious Diseases. 128: Suppl:S320-6. PMID 4200651 DOI: 10.1093/Infdis/128.Supplement_2.S320  0.319
1973 Bach MC, Finland M, Gold O, Wilcox C. Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined. The Journal of Infectious Diseases. 128: Suppl:508-33 p. PMID 4148416 DOI: 10.1093/Infdis/128.Supplement_3.S508  0.301
1973 Finland M, Kass EH. Summary and comments on the conference Journal of Infectious Diseases. 128: S792-S816.  0.399
1972 Bach MC, Zinner SH, Wilcox C, Finland M. Efficacy of standard disc-diffusion test as applied to susceptibility of Staphylococcus aureus to tetracycline and minocycline. The Journal of Laboratory and Clinical Medicine. 79: 316-25. PMID 5009717 DOI: 10.5555/Uri:Pii:0022214372900923  0.334
1972 Finland M. Perspective. Hospital-acquired infections: the problems of methicillin-resistant Staphylococcus aureus and infections with Klebsiella pneumoniae. The American Journal of the Medical Sciences. 264: 207-11. PMID 4486504 DOI: 10.1097/00000441-197209000-00006  0.362
1972 Finland M. Changing patterns of susceptibility of common bacterial pathogens to antimicrobial agents. Annals of Internal Medicine. 76: 1009-36. PMID 4402139 DOI: 10.7326/0003-4819-76-6-1009  0.351
1972 Finland M. Osteomyelitis: Clinical Features, Therapeutic Considerations, and Unusual Aspects. Jama Internal Medicine. 130: 298-299. DOI: 10.1001/Archinte.1972.03650020114022  0.376
1971 Adler JL, Burke JP, Finland M. Infection and antibiotic usage at Boston City Hospital, January 1970. Archives of Internal Medicine. 127: 460-5. PMID 5544315 DOI: 10.1001/Archinte.1971.00310150120016  0.358
1971 Burke JP, Ingall D, Klein JO, Gezon HM, Finland M. Proteus mirabilis infections in a hospital nursery traced to a human carrier. The New England Journal of Medicine. 284: 115-21. PMID 5538678 DOI: 10.1056/Nejm197101212840301  0.311
1971 Finland M. I. Prevalence of extrachromosomal drug resistance. Changes in asusceptibility of selected pathogenic bacteria to widely used antibiotics. Annals of the New York Academy of Sciences. 182: 5-20. PMID 4398292 DOI: 10.1111/J.1749-6632.1971.Tb30639.X  0.311
1971 Burke JP, Klein JO, Gezon HM, Finland M. Pneumococcal bacteremia. Review of 111 cases, 1957--1969, with special reference to cases with undetermined focus. American Journal of Diseases of Children (1960). 121: 353-9. PMID 4396753 DOI: 10.1001/Archpedi.1971.02100150127021  0.353
1971 Finland M. Increased resistance in the pneumococcus. The New England Journal of Medicine. 284: 212-4. PMID 4395335 DOI: 10.1056/Nejm197101282840411  0.365
1971 Adler JL, Finland M. Susceptibility of recent isolates of Pseudomonas aeruginosa to gentamicin, polymyxin, and five penicillins, with observations on the pyocin and immunotypes of the strains. Applied Microbiology. 22: 870-5. PMID 4332044 DOI: 10.1128/Aem.22.5.870-875.1971  0.331
1971 Zinner SH, Sabath LD, Casey JI, Finland M. Erythromycin and alkalinisation of urine in the treatment of urinary-tract infections due to gram-negative bacilli. Lancet. 1: 1267-8. PMID 4104718 DOI: 10.1016/S0140-6736(71)91780-6  0.364
1971 Finland M. The John Phillips Memorial Lecture: Changing Patterns of Susceptibility of Some Common Bacterial Pathogens to Antimicrobial Agents. Annals of Internal Medicine. 74: 843-843. DOI: 10.7326/0003-4819-74-5-843_5  0.33
1971 Finland M. Antimicrobial Agents and Chemotherapy—1969. Jama Internal Medicine. 128: 150-151. DOI: 10.1001/Archinte.1971.00310190154023  0.318
1970 Toala P, Schroeder SA, Daly AK, Finland M. Candida at Boston City Hospital. Clinical and epidemiological characteristics and susceptibility to eight antimicrobial agents. Archives of Internal Medicine. 126: 983-9. PMID 5483601 DOI: 10.1001/Archinte.1970.00310120045004  0.363
1970 Finland M. Changing ecology of bacterial infections as related to antibacterial therapy. The Journal of Infectious Diseases. 122: 419-31. PMID 5476392 DOI: 10.1093/Infdis/122.5.419  0.347
1970 Barrett FF, Casey JI, Wilcox C, Finland M. Bacteriophage types and antibiotic susceptibility of Staphylococcus aureus. Boston City Hospital, 1967. Archives of Internal Medicine. 125: 867-73. PMID 5444315 DOI: 10.1001/Archinte.1970.00310050105013  0.33
1970 Sabath LD, Gerstein DA, Leaf CD, Finland M. Increasing the usefulness of antibiotics: Treatment of infections caused by gram-negative bacilli. Clinical Pharmacology and Therapeutics. 11: 161-7. PMID 5198094 DOI: 10.1002/Cpt1970112161  0.372
1970 Sabath LD, Leaf CD, Gerstein DA, Finland M. Altered cell walls of Staphylococcus aureus resistant to methicillin. Nature. 225: 1074. PMID 5198089 DOI: 10.1038/2251074A0  0.327
1970 Toala P, Wilcox C, Finland M. Effect of pH of medium and size of inoculum on activity of antibiotics against group D Streptococcus (Enterococcus). Applied Microbiology. 19: 629-37. PMID 4986728 DOI: 10.1128/Aem.19.4.629-637.1970  0.303
1970 Dans PE, McGehee RF, Wilcox C, Finland M. Rifampin: antibacterial activity in vitro and absorption and excretion in normal young men. The American Journal of the Medical Sciences. 259: 120-32. PMID 4984031 DOI: 10.1097/00000441-197002000-00006  0.341
1970 Wilfert JN, Barrett FF, Ewing WH, Finland M, Kass EH. Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital. Applied Microbiology. 19: 345-52. PMID 4314379 DOI: 10.1128/Aem.19.2.345-352.1970  0.55
1970 Barrett FF, Casey JI, Wilcox C, Finland M. Bacteriophage types and antibiotic susceptibility of Staphylococcus aureus. Jama Internal Medicine. 125. DOI: 10.1001/Archinte.125.5.867  0.346
1969 Castle WB, Astwood EB, Finland M, Keefer CS. White paper on the therapeutic equivalence of chemically equivalent drugs. Jama. 208: 1171-2. PMID 5818716 DOI: 10.1001/Jama.1969.03160070049012  0.513
1969 Lorian V, Finland M. In vitro effect of rifampin on mycobacteria. Applied Microbiology. 17: 202-7. PMID 4975656 DOI: 10.1128/Aem.17.2.202-207.1969  0.303
1969 Tillotson JR, Finland M. Bacterial colonization and clinical superinfection of the respiratory tract complicating antibiotic treatment of pneumonia. The Journal of Infectious Diseases. 119: 597-624. PMID 4893892 DOI: 10.1093/Infdis/119.6.597  0.382
1969 Klein JO, Green GM, Tilles JG, Kass EH, Finland M. Effect of intranasal reovirus infection on antibacterial activity of mouse lung. The Journal of Infectious Diseases. 119: 43-50. PMID 4303795 DOI: 10.1093/Infdis/119.1.43  0.543
1969 Finland M. Communicable and Infectious Diseases, ed 6. Jama Internal Medicine. 123: 473-473. DOI: 10.1001/Archinte.1969.00300140119030  0.31
1968 Steigbigel NH, Kislak JW, Tilles JG, Finland M. Clinical evaluation of cephaloridine. Archives of Internal Medicine. 121: 24-38. PMID 5635071 DOI: 10.1001/Archinte.121.1.24  0.404
1968 Barrett FF, Casey JI, Finland M. Infections and antibiotic use among patients at Boston City Hospital, February, 1967. The New England Journal of Medicine. 278: 5-9. PMID 5634656 DOI: 10.1056/Nejm196801042780102  0.351
1968 Sabath LD, Loder PB, Gerstein DA, Finland M. Measurement of three antibiotics (penicillin, cephalothin, and chloramphenicol) when present together in mixtures. Applied Microbiology. 16: 877-80. PMID 5187067 DOI: 10.1128/Aem.16.6.877-880.1968  0.308
1968 Sabath LD, Lorian V, Gerstein D, Loder PB, Finland M. Enhancing effect on alkalinization of the medium on the activity of erythromycin against gram-negative bacteria. Applied Microbiology. 16: 1288-92. PMID 4970991 DOI: 10.1128/Aem.16.9.1288-1292.1968  0.308
1968 Smith CB, Finland M. Carbenicillin: activity in vitro and absorption and excretion in normal young men. Applied Microbiology. 16: 1753-60. PMID 4387223 DOI: 10.1128/Aem.16.11.1753-1760.1968  0.306
1968 Braun P, Tillotson JR, Wilcox C, Finland M. Cephalexin and cephaloglycin activity in vitro and absorption and urinary excretion of single oral doses in normal young adults. Applied Microbiology. 16: 1684-94. PMID 4387222 DOI: 10.1128/Aem.16.11.1684-1694.1968  0.345
1968 Barrett FF, McGehee RF, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. The New England Journal of Medicine. 279: 441-8. PMID 4232865 DOI: 10.1056/Nejm196808292790901  0.309
1968 Finland M. Nutrition and Infection The American Journal of the Medical Sciences. 256: 380. DOI: 10.1097/00000441-196812000-00009  0.313
1967 Sabath LD, Elder HA, McCall CE, Finland M. Synergistic combinations of penicillins in the treatment of bacteriuria. The New England Journal of Medicine. 277: 232-8. PMID 4961731 DOI: 10.1056/Nejm196708032770503  0.334
1967 Steigbigel NH, McCall CE, Reed CW, Finland M. Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients. Annals of the New York Academy of Sciences. 145: 224-36. PMID 4327436 DOI: 10.1111/J.1749-6632.1967.Tb50221.X  0.338
1967 Klein JO, Green GM, Tilles JG, Kass EH, Finland M. Bactericidal activity of mouse lung in reovirus infection. Antimicrobial Agents and Chemotherapy. 7: 164-7. PMID 4299354  0.447
1966 Eickhoff TC, Steinhauer BW, Finland M. The Klebsiella-Enterobacter-Serratia division. Biochemical and serologic characteristics and susceptibility to antibiotics. Annals of Internal Medicine. 65: 1163-79. PMID 5928478 DOI: 10.7326/0003-4819-65-6-1163  0.362
1965 Kislak JW, Razavi LM, Daly AK, Finland M. Susceptibility of pneumococci to nine antibiotics. The American Journal of the Medical Sciences. 250: 261-8. PMID 4378532 DOI: 10.1097/00000441-196509000-00003  0.354
1965 Eickhoff TC, Kislak JW, Finland M. Clinical Evaluation of Nafcillin in Patients with Severe Staphylococcal Disease The New England Journal of Medicine. 272: 699-708. DOI: 10.1056/Nejm196504082721401  0.361
1964 KISLAK JW, EICKHOFF TC, FINLAND M. HOSPITAL-ACQUIRED INFECTIONS AND ANTIBIOTIC USAGE IN THE BOSTON CITY HOSPITAL--JANUARY, 1964. The New England Journal of Medicine. 271: 834-5. PMID 14187670 DOI: 10.1056/Nejm196410152711608  0.333
1963 KJELLANDER JO, KLEIN JO, FINLAND M. IN VITRO ACTIVITY OF PENICILLINS AGAINST STAPHYLOCOCCUS ALBUS. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 113: 1023-31. PMID 14073098 DOI: 10.3181/00379727-113-28563  0.325
1963 KLEIN JO, SABATH LD, STEINHAUER BW, FINLAND M. TREATMENT OF SEVERE STAPHYLOCOCCAL INFECTIONS WITH ANCILLIN. The American Journal of the Medical Sciences. 246: 385-403. PMID 14070687 DOI: 10.1097/00000441-196310000-00001  0.329
1963 REMINGTON JS, DALRYMPLE W, JACOBS L, FINLAND M. TOXOPLASMA ANTIBODIES AMONG COLLEGE STUDENTS. The New England Journal of Medicine. 269: 1394-8. PMID 14064327 DOI: 10.1056/Nejm196312262692602  0.475
1963 KLEIN JO, SABATH LD, STEINHAUER BW, FINLAND M. OXACILLIN TREATMENT OF SEVERE STAPHYLOCOCCAL INFECTIONS. The New England Journal of Medicine. 269: 1215-25. PMID 14060566 DOI: 10.1056/Nejm196312052692301  0.363
1963 MERLER E, REMINGTON JS, FINLAND M, GITLIN D. CHARACTERIZATION OF ANTIBODIES IN NORMAL HUMAN URINE. The Journal of Clinical Investigation. 42: 1340-52. PMID 14060404 DOI: 10.1172/Jci104818  0.446
1963 KJELLANDER JO, FINLAND M. PENICILLIN TREATMENT OF GONORRHEAL URETHRITIS. EFFECTS OF PENICILLIN SUSCEPTIBILITY OF CAUSATIVE ORGANISM AND CONCOMITANT PRESENCE OF PENICILLINASE- PRODUCING BACTERIA ON RESULTS. The New England Journal of Medicine. 269: 834-6. PMID 14052266 DOI: 10.1056/Nejm196310172691603  0.338
1963 SABATH LD, STEINHAUER BW, FINLAND M. Combined action of penicillin G with methicillin or oxacillin against Staphylococcus aureus. The New England Journal of Medicine. 268: 284-6. PMID 13975858 DOI: 10.1056/Nejm196302072680603  0.359
1963 LERNER AM, CHERRY JD, FINLAND M. Hemagglutination with reoviruses. Virology. 19: 58-65. PMID 13929839 DOI: 10.1016/0042-6822(63)90024-2  0.309
1962 REMINGTON JS, MERLER E, LERNER AM, GITLIN D, FINLAND M. Antibodies of low molecular weight in normal human urine. Nature. 194: 407-8. PMID 14491399 DOI: 10.1038/194407A0  0.453
1962 REMINGTON JS, FINLAND M. Antibacterial activity of serum after oral doses of tetracycline, demethylchlortetracycline, and 6-methyleneoxytetracycline. Clinical Pharmacology and Therapeutics. 3: 284-304. PMID 14491396 DOI: 10.1002/cpt196233284  0.395
1962 LERNER AM, REMINGTON JS, FINLAND M. Neutralizing antibody to polioviruses in normal human urine. The Journal of Clinical Investigation. 41: 805-15. PMID 14464245 DOI: 10.1172/Jci104538  0.446
1962 SABATH LD, POSTIC B, FINLAND M. Laboratory studies on methicillin. With special reference to patients treated for staphylococcal infections. The American Journal of the Medical Sciences. 244: 484-500. PMID 13975860 DOI: 10.1097/00000441-196210000-00010  0.352
1962 SABATH LD, POSTIC B, FINLAND M. Methicillin treatment of severe staphylococcal disease. Observations in 146 cases. The New England Journal of Medicine. 267: 1049-57. PMID 13975859 DOI: 10.1056/Nejm196211222672101  0.361
1962 BENNETT IL, FINLAND M, HAMBURGER M, KASS EH, LEPPER M, WAISBREN BA. A double-blind study of the effectiveness of cortisol in the management of severe infections. Transactions of the Association of American Physicians. 75: 198-207. PMID 13967471  0.456
1962 MERLER E, REMINGTON JS, FINLAND M, GITLIN D. Differences between urinary albumin and serum albumin. Nature. 196: 1207-8. PMID 13935017 DOI: 10.1038/1961207A0  0.451
1961 REMINGTON JS, FINLAND M. Precipitating antibody in normal human urine. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 107: 765-70. PMID 14491397 DOI: 10.3181/00379727-107-26748  0.444
1961 POSTIC B, FINLAND M. In vitro susceptibility of recently isolated strains of Pseudomonas aeruginosa to ten antibiotics. The American Journal of the Medical Sciences. 242: 551-9. PMID 14488220 DOI: 10.1097/00000441-196111000-00004  0.328
1961 WALLMARK G, FINLAND M. Phage types and antibiotic susceptibility of pathogenic staphylococci. Results at Boston City Hospital 1959-1960 and comparison with strains of previous years. Jama. 175: 886-97. PMID 13782866 DOI: 10.1001/Jama.1961.63040100007012  0.336
1961 WALLMARK G, FINLAND M. New phages active against staphylococci that are resistant to the conventional phage set. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 106: 73-8. PMID 13782865 DOI: 10.3181/00379727-106-26243  0.339
1961 MCCARTHY CG, FINLAND M. Furaltadone. Antibacterial activity in vitro and in serum of patients during treatment. Archives of Internal Medicine. 107: 863-71. PMID 13773763 DOI: 10.1001/Archinte.1961.03620060063008  0.402
1961 LERNER AM, REMINGTON JS, FINLAND M. Neutralizing antibody to polioviruses in normal human urine. Virology. 14: 383-5. PMID 13761075 DOI: 10.1016/0042-6822(61)90327-0  0.446
1961 KUNIN CM, FINLAND M. Clinical pharmacology of the tetracycline antibiotics. Clinical Pharmacology and Therapeutics. 2: 51-69. PMID 13755136 DOI: 10.1002/Cpt19612151  0.529
1960 KUNIN CM, FINLAND M. Absorption and urinary excretion of chloramphenicol and 2 analogues, thiocymetin and U-15, 442 in normal men. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 103: 246-50. PMID 14412749 DOI: 10.3181/00379727-103-25475  0.519
1960 KUNIN CM, CHALMERS TC, LEEVY CM, SEBASTYEN SC, LIEBER CS, FINLAND M. Absorption of orally administered neomycin and kanamycin with special reference to patients with severe hepatic and renal disease. The New England Journal of Medicine. 262: 380-5. PMID 14412744 DOI: 10.1056/Nejm196002252620802  0.522
1960 HIRSCH HA, McCARTHY CG, FINLAND M. Polymyxin B and colistin: activity, resistance and crossresistance in vitro. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 103: 338-42. PMID 14401972 DOI: 10.3181/00379727-103-25511  0.349
1960 FINLAND M, HIRSCH HA, WALLMARK G. Pathogenic staphylococci isolated at Boston City Hospital in 1958: phage types and antibiotic susceptibility. Archives of Internal Medicine. 105: 383-97. PMID 13822923 DOI: 10.1001/Archinte.1960.00270150037005  0.368
1960 LERNER AM, KLEIN JO, FINLAND M. A laboratory outbreak of infections with Coxsackie virus group A, type 9. The New England Journal of Medicine. 263: 1302 4. PMID 13761072 DOI: 10.1056/Nejm196012222632509  0.337
1960 Welch H, Finland M. Antibiotics Monographs No. 12. Antibiotic Therapy For Staphylococcal Diseases The American Journal of the Medical Sciences. 240: 399. DOI: 10.1097/00000441-196009000-00022  0.309
1960 Finland M. The Clinical Application of Antibiotics. Volume IV: Erythromycin and Other Antibiotics Jama. 173: 1863-1863. DOI: 10.1001/Jama.1960.03020340081034  0.306
1959 KUNIN CM, REES SB, MERRILL JP, FINLAND M. Persistence of antibiotics in blood of patients with acute renal failure. I. Tetracycline and chlortetracycline. The Journal of Clinical Investigation. 38: 1487-97. PMID 14412754 DOI: 10.1172/Jci103927  0.494
1959 KUNIN CM, GLAZKO AJ, FINLAND M. Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis. The Journal of Clinical Investigation. 38: 1498-508. PMID 14412753 DOI: 10.1172/Jci103928  0.483
1959 KUNIN CM, FINLAND M. Restrictions imposed on antibiotic therapy by renal failure. Archives of Internal Medicine. 104: 1030-50. PMID 14412752 DOI: 10.1001/Archinte.1959.00270120186021  0.5
1959 KUNIN CM, FINLAND M. Persistence of antibiotics in blood of patients with acute renal failure. III. Penicillin, streptomycin, erythromycin and kanamycin. The Journal of Clinical Investigation. 38: 1509-19. PMID 14412751 DOI: 10.1172/Jci103929  0.501
1959 KUNIN CM, FINLAND M. Excretion of demethylchlortetracycline into the bile. The New England Journal of Medicine. 261: 1069-71. PMID 14412750 DOI: 10.1056/Nejm195911192612107  0.539
1959 KUNIN CM, DORNBUSH AC, FINLAND M. The distribution and excretion of four tetracycline analogues in normal young men. Antibiotics Annual. 7: 386-7. PMID 14412747  0.385
1959 KUNIN CM, DORNBUSH AC, FINLAND M. Distribution and excretion of four tetracycline analogues in normal young men. The Journal of Clinical Investigation. 38: 1950-63. PMID 14412746 DOI: 10.1172/Jci103974  0.454
1959 KUNIN CM, CHALMERS TG, LEEVY CM, SEBASTYEN SC, LIEBER CS, FINLAND M. Absorption of orally administered neomycin and kanamycin, with special reference to patients with severe hepatic and renal diseases. Antibiotics Annual. 7: 489-90. PMID 14412745  0.41
1959 HIRSCH HA, KUNIN CM, FINLAND M. [Demethylchlortetracycline. A new and more stable antibiotic of the tetracycline group with a stronger and longer-acting antibacterial effect]. Mã¼Nchener Medizinische Wochenschrift (1950). 101: 1311-5. PMID 13852431  0.456
1959 FINLAND M, JONES WF, BENNETT IL. Antibiotic susceptibility and phage type of pathogenic staphylocci: a study of two hundred ten strains isolated at Boston City Hospital in 1955. Archives of Internal Medicine. 104: 365-77. PMID 13822925 DOI: 10.1001/Archinte.1959.00270090019004  0.355
1959 FINLAND M, HIRSCH HA, KUNIN CM. Observations on demethylchlortetracycline. Antibiotics Annual. 7: 375-82. PMID 13822922  0.374
1959 HIRSCH HA, FINLAND M. Antibacterial activity of serum of normal subjects after oral doses of demethylchlortetracycline, chlortetracycline and oxytetracycline. The New England Journal of Medicine. 260: 1099-104. PMID 13657347 DOI: 10.1056/Nejm195905282602201  0.312
1959 MARTIN CM, KUNIN CM, GOTTLIEB LS, FINLAND M. Asian influenza A in Boston, 1957-1958. II. Severe staphylococcal pneumonia complicating influenza. A.M.a. Archives of Internal Medicine. 103: 532-42. PMID 13636471 DOI: 10.1001/Archinte.1959.00270040018002  0.538
1959 MARTIN CM, KUNIN CM, GOTTLIEB LS, BARNES MW, LIU C, FINLAND M. Asian influenza A in Boston, 1957-1958. I. Observations in thirty-two influenza-associated fatal cases. A.M.a. Archives of Internal Medicine. 103: 515-31. PMID 13636470 DOI: 10.1001/Archinte.1959.00270040001001  0.496
1959 HIRSCH HA, KUNIN CM, FINLAND M. Antibacterial activity of serum of normal men after oral doses of erythromycin propionate and triacetyloleandomycin. The New England Journal of Medicine. 260: 408-12. PMID 13632901 DOI: 10.1056/NEJM195902262600902  0.419
1959 KUNIN CM, SCHWARTZ R, YAFFE S, KNAPP J, FELLERS FX, JANEWAY CA, FINLAND M. Antibody response to influenza-virus vaccine in children with nephrosis: effect of cortisone. Pediatrics. 23: 54-62. PMID 13613864  0.404
1958 KUNIN CM, HIRSCH HA, FINLAND M. Absorption of erythromycin propionate and triacetyloleandomycin. Antibiotics Annual. 6: 382. PMID 13637769  0.384
1958 KASS EH, FINLAND M. Corticosteroids and infections. Advances in Internal Medicine. 9: 45-80. PMID 13636912  0.479
1958 KUNIN CM, WILCOX C, NAJARIAN A, FINLAND M. Susceptibility and crossresistance of bacteria to four related antibiotics: kanamycin, paromomycin, neomycin and streptomycin. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 99: 312-6. PMID 13601854 DOI: 10.3181/00379727-99-24334  0.55
1958 KUNIN CM, FINLAND M. Demethylchlortetracycline; a new tetracycline antibiotic that yields greater and more sustained antibacterial activity. The New England Journal of Medicine. 259: 999-1005. PMID 13600611 DOI: 10.1056/Nejm195811202592102  0.517
1958 FINLAND M. Antibiotic for staphylococcal infections. The Medical Clinics of North America. 42: 1179-94. PMID 13599740 DOI: 10.1016/S0025-7125(16)34216-X  0.366
1958 KUNIN CM, FINLAND M. Susceptibility and cross resistance of bacteria to streptomycin, neomycin, paromomycin, and kanamycin. Annals of the New York Academy of Sciences. 76: 42-3. PMID 13595492 DOI: 10.1111/J.1749-6632.1958.Tb54691.X  0.511
1958 KUNIN CM, PRYLES CV, FINLAND M. Antibacterial activity of serum after oral doses of triacetyloleandomycin, erythromycin, potassium penicillin V and penicillin V. Pediatrics. 22: 422-31. PMID 13578533  0.419
1958 KUNIN CM, JONES WF, FINLAND M. [Enhancement of tetracycline blood levels]. The New England Journal of Medicine. 259: 147-56. PMID 13566438 DOI: 10.1056/NEJM195807242590401  0.386
1958 GABUZDA GJ, GOCKE TM, JACKSON GG, GRIGSBY ME, DEL LOVE B, FINLAND M. Some effects of antibiotics on nutrition in man; including studies of the bacterial flora of the feces. A.M.a. Archives of Internal Medicine. 101: 476-513. PMID 13497351 DOI: 10.1001/Archinte.1958.00260140308042  0.529
1958 FINLAND M, BARNES MW. Cold agglutinins. VIII. Occurrence of cold isohemagglutinins in patients with primary atypical pneumonia or influenza viral infection, Boston City Hospital, June, 1950, to July, 1956. A.M.a. Archives of Internal Medicine. 101: 462-6. PMID 13497349 DOI: 10.1001/Archinte.1958.00260140294040  0.373
1958 FINLAND M. Current status of therapy in bacterial endocarditis. Journal of the American Medical Association. 166: 364-73. PMID 13491348 DOI: 10.1001/Jama.1958.62990040007010  0.387
1957 JONES WF, FINLAND M. Antibiotic combinations; tetracycline, erythromycin, oleandomycin and spiramycin, and combinations of tetracycline with each of the other three agents; comparisons of activity in vitro and antibacterial action of blood after oral administration. The New England Journal of Medicine. 257: 481-91 contd. PMID 13464964 DOI: 10.1056/Nejm195709122571101  0.314
1957 FINLAND M. Staphylococci, antibiotics, and endocarditis. Circulation. 15: 641-5. PMID 13427119 DOI: 10.1161/01.Cir.15.5.641  0.357
1957 KASS EH, FINLAND M. Adrenocortical hormones and the management of infection. Annual Review of Medicine. 8: 1-18. PMID 13425323 DOI: 10.1146/Annurev.Me.08.020157.000245  0.507
1957 JONES WF, FELDMAN HA, FINLAND M. Susceptibility of hemolytic streptococci, other than those of group D, to eleven antibiotics in vitro. American Journal of Clinical Pathology. 27: 159-69. PMID 13410849 DOI: 10.1093/Ajcp/27.2.159  0.339
1957 Dowling HF, Finland M, Hamburger M, Jawetz E, Knight V, Lepper MH, Meiklejohn G, Rantz LA, Rhoads PS. The Clinical Use of Antibiotics in Combination A.M.a Archives of Internal Medicine. 99: 536-538. PMID 13410158 DOI: 10.1001/Archinte.1957.00260040036003  0.634
1957 JONES WF, FINLAND M. Susceptibility of pneumococci to eleven antibiotics in vitro. The American Journal of the Medical Sciences. 233: 312-9. PMID 13402763 DOI: 10.1097/00000441-195703000-00012  0.356
1956 Jones WF, Nichols RL, Finland M. Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin. Experimental Biology and Medicine. 93: 388-393. PMID 13379520 DOI: 10.3181/00379727-93-22766  0.305
1956 Finland M, Jones WF. Staphylococcal Infections Currently Encountered In A Large Municipal Hospital: Some Problems In Evaluating Antimicrobial Therapy In Such Infections Annals of the New York Academy of Sciences. 65: 191-205. PMID 13363214 DOI: 10.1111/J.1749-6632.1956.Tb36638.X  0.328
1955 Finland M. Antibiotic-Resistant Micrococcic Infections: Guest Editorial Jama. 158: 188-190. PMID 14367069 DOI: 10.1001/Jama.1955.02960030038012  0.365
1955 Finland M. Changing Patterns of Resistance of Certain Common Pathogenic Bacteria to Antimicrobial Agents The New England Journal of Medicine. 252: 570-580. PMID 14356383 DOI: 10.1056/Nejm195504072521404  0.32
1955 Finland M. Emergence of antibiotic-resistant bacteria. The New England Journal of Medicine. 253: 1019-1028. PMID 13272814 DOI: 10.1056/Nejm195511242532105  0.311
1955 KASS EH, KENDRICK MI, FINLAND M. Effects of corticosterone, hydrocortisone, and corticotropin on production of antibodies in rabbits. The Journal of Experimental Medicine. 102: 767-74. PMID 13271688 DOI: 10.1084/Jem.102.6.767  0.478
1955 RICHARDS WA, RISS E, KASS EH, FINLAND M. Nitrofurantoin; clinical and laboratory studies in urinary tract infections. A.M.a. Archives of Internal Medicine. 96: 437-50. PMID 13257939 DOI: 10.1001/Archinte.1955.00250150011001  0.539
1955 Love BD, Finland M. Susceptibility of neisseria gonorrhoeae to eleven antibiotics and sulfadiazine: Comparison of Susceptibility of Recently Isolated Strains with Results Obtained in Previous Years in the Same Laboratory A.M.a Archives of Internal Medicine. 95: 66-73. PMID 13217505 DOI: 10.1001/Archinte.1955.00250070082010  0.341
1954 Love BD, Finland M. Susceptibility of recently isolated strains of Hemophilus influenzae to eleven antibiotics in vitro The Journal of Pediatrics. 45: 531-537. PMID 13212594 DOI: 10.1016/S0022-3476(54)80115-6  0.327
1954 LOVE BD, FINLAND M. In vitro susceptibility of meningococci to eleven antibiotics and sulfadiazine The American Journal of the Medical Sciences. 228: 534-539. PMID 13207113 DOI: 10.1097/00000441-195411000-00006  0.357
1954 JACKSON GG, GABUZDA GJ, FINLAND M. Effect of antibiotics on organisms used in certain microbiologic assays of essential nutrients. The Journal of Laboratory and Clinical Medicine. 44: 449-62. PMID 13201855  0.443
1954 Finland M. Treatment of Bacterial Endocarditis The New England Journal of Medicine. 250: 372-383. PMID 13144972 DOI: 10.1056/Nejm195403112501005  0.332
1954 WRIGHT SS, PURCELL EM, WILCOX C, BRODERICK MK, FINLAND M. Antibiotic combinations and resistance: response of E. coli to antibiotics, singly and in pairs. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 85: 128-33. PMID 13134311 DOI: 10.3181/00379727-85-20807  0.328
1954 Finland M. Treatment of bacterial endocarditis; dosage of penicillin, use of other antibiotics and treatment of patients with negative blood cultures. Circulation. 9: 292-299. PMID 13127191 DOI: 10.1161/01.Cir.9.2.292  0.318
1954 KASS EH, LUNDGREN MM, FINLAND M. The effect of adrenal steroids, corticotropin, and growth hormone on resistance to experimental infections. The Journal of Experimental Medicine. 99: 89-104. PMID 13118066 DOI: 10.1084/Jem.99.1.89  0.548
1954 FINLAND M, PURCELL EM, WRIGHT SS, LOVE BD, MOU TW, KASS EH. Clinical and laboratory observations of a new antibiotic, tetracycline. Journal of the American Medical Association. 154: 561-8. PMID 13117662 DOI: 10.1001/Jama.1954.02940410017005  0.531
1954 Finland M, Grigsby ME, Haight TH. Efficacy and toxicity of oxytetracycline (terramycin) and chlortetracycline (aureomycin): With Special Reference to Use of Doses of 250 Mg. Every Four to Six Hours and to Occurrence of Staphylococcic Diarrhea A.M.a Archives of Internal Medicine. 93: 23-43. PMID 13103847 DOI: 10.1001/Archinte.1954.00240250033003  0.371
1953 KASS EH, LUNDGREN MM, FINLAND M. Observations on the effect of corticosteroids and growth hormone on resistance to experimental pneumococcal and influenza virus infections. Annals of the New York Academy of Sciences. 56: 765-71. PMID 13208070 DOI: 10.1111/J.1749-6632.1953.Tb27400.X  0.541
1953 KASS EH, KENDRICK MI, FINLAND M. Effect of certain corticosteroids and of growth hormone of nucleoproteins of lymph nodes. Annals of the New York Academy of Sciences. 56: 737-41. PMID 13208066 DOI: 10.1111/J.1749-6632.1953.Tb27396.X  0.442
1953 KASS EH, FINLAND M. Adrenocortical hormones in infection and immunity. Annual Review of Microbiology. 7: 361-88. PMID 13139395 DOI: 10.1146/Annurev.Mi.07.100153.002045  0.51
1953 Finland M, Wilcox C. Antibiotic combinations and resistance to antibiotics: penicillin with other antibiotics against penicillin-resistant staphylococci. Experimental Biology and Medicine. 83: 605-608. PMID 13088924 DOI: 10.3181/00379727-83-20433  0.326
1953 WRIGHT SS, PURCELL EM, KASS EH, FINLAND M. Penicillin G and benzethacil by mouth: comparison of penicillin levels in plasma of normal men after single oral doses. The Journal of Laboratory and Clinical Medicine. 42: 417-29. PMID 13085032 DOI: 10.5555/Uri:Pii:0022214353902558  0.469
1953 PURCELL EM, WRIGHT SS, FINLAND M. Antibiotic combinations and resistance to antibiotics; penicillin-erythromycin and streptomycin-erythromycin combinations in vitro. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 82: 124-31. PMID 13037821 DOI: 10.3181/00379727-82-20042  0.357
1953 FINLAND M, HAIGHT TH. Antibiotic resistance of pathogenic staphylococci; study of five hundred strains isolated at Boston City Hospital from October, 1951, to February, 1952. A.M.a. Archives of Internal Medicine. 91: 143-58. PMID 13016035 DOI: 10.1001/Archinte.1953.00240140003001  0.303
1952 Finland M. Antimicrobial treatment for viral and related infections. I. Antibiotic treatment of primary atypical pneumonia. The New England Journal of Medicine. 247: 317-325. PMID 14957224 DOI: 10.1056/Nejm195208282470904  0.379
1952 KASS EH, AYCOCK RR, FINLAND M. Clinical evaluation of aureomycin and chloramphenicol in herpes zoster. The New England Journal of Medicine. 246: 167-72. PMID 14890830 DOI: 10.1056/Nejm195201312460502  0.506
1952 WOMACK CR, JACKSON GG, GOCKE TM, KASS EH, HAIGHT TH, FINLAND M. Terramycin therapy of urinary tract infections. A.M.a. Archives of Internal Medicine. 89: 240-57. PMID 14884789 DOI: 10.1001/Archinte.1952.00240020072005  0.665
1952 FINLAND M, WILCOX C, WRIGHT SS, PURCELL EM. Cross resistance to antibiotics: effect of exposures of bacteria to carbomycin or erythromycin in vitro. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 81: 725-9. PMID 13037779 DOI: 10.3181/00379727-81-20000  0.35
1952 GRIGSBY ME, HAIGHT TH, FINLAND M. Some clinical and laboratory observations on the hydriodide of The New England Journal of Medicine. 247: 807-811. PMID 13002621 DOI: 10.1056/Nejm195211202472106  0.314
1952 Finland M. Antimicrobial treatment for viral and related infections. II. Antibiotic treatment of acute respiratory infections and influenza. The New England Journal of Medicine. 247: 557-567. PMID 12993270 DOI: 10.1056/Nejm195210092471505  0.362
1952 Finland M. Antibiotic treatment of viral diseases. Medical Clinics of North America. 36: 1239-1252. DOI: 10.1016/S0025-7125(16)35090-8  0.306
1951 JACKSON GG, HAIGHT TH, KASS EH, WOMACK CR, GOCKE TM, FINLAND M. Terramycin therapy of pneumonia: clinical and bacteriologic studies in 91 cases. Annals of Internal Medicine. 35: 1175-1202. PMID 14895000 DOI: 10.7326/0003-4819-35-6-1175  0.666
1951 FINLAND M, JACKSON GG, KASS EH, HAIGHT TH, WOMACK CR. Some recent observations on staphylococcal infections in relation to antibiotic therapy. Transactions of the Association of American Physicians. 64: 343-4. PMID 14884268  0.618
1951 KASS EH, GEIMAN QM, FINLAND M. Effects of ACTH on induced malaria in man. The New England Journal of Medicine. 245: 1000-2. PMID 14882469 DOI: 10.1056/Nejm195112272452602  0.483
1951 JACKSON GG, FINLAND M. Comparison of methods for determining sensitivity of bacteria to antibiotics in vitro. A.M.a. Archives of Internal Medicine. 88: 446-60. PMID 14867952 DOI: 10.1001/Archinte.1951.03810100030003  0.544
1951 JACKSON GG, FINLAND M. Turbidimetric method for determining sensitivity of bacteria to antibiotics. The Journal of Laboratory and Clinical Medicine. 38: 289-307. PMID 14861530 DOI: 10.5555/Uri:Pii:0022214351900613  0.509
1951 KASS EH, FINLAND M. The role of steroids in infection and immunity. Pediatrics. 8: 137-8. PMID 14853629  0.448
1951 HAZEN LN, JACKSON GG, CHANG SM, PLACE EH, FINLAND M. Antibiotic treatment of pertussis; comparison of penicillin, aureomycin, chloramphenicol, and terramycin in 150 cases. The Journal of Pediatrics. 39: 1-15. PMID 14851180 DOI: 10.1016/S0022-3476(51)80275-0  0.528
1951 KASS EH, NEVA FA, FINLAND M. Failure of ACTH to protect against acutely lethal toxins of influenza virus and rickettsiae. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 76: 560-3. PMID 14844274 DOI: 10.3181/00379727-76-18557  0.488
1951 KASS EH, INGBAR SH, LUNDGREN MM, FINLAND M. The effect of ACTH and cortisone on pneumococcal and influenza viral infections in the white mouse. The Journal of Laboratory and Clinical Medicine. 37: 780-8. PMID 14841421  0.475
1951 KASS EH, LUNDGREN MM, FINLAND M. Effect of ACTH on leucocyte counts in white mice. The Journal of Laboratory and Clinical Medicine. 37: 458-63. PMID 14824669  0.385
1951 KASS EH, FINLAND M. The role of adrenal steroids in infection and immunity. The New England Journal of Medicine. 244: 464-70. PMID 14806785 DOI: 10.1056/Nejm195103292441302  0.529
1951 FINLAND M, BARNES MW. Cold agglutinins. VII. tests for cold isohemagglutinins in pneumonia and other acute respiratory infections over a four-year period The American Journal of the Medical Sciences. 221: 152-157. PMID 14799478 DOI: 10.1097/00000441-195102000-00006  0.312
1951 Neva FA, Nelson RJ, Finland M. Hospital Outbreak of Infections with Salmonella newington The New England Journal of Medicine. 244: 252-255. PMID 14796824 DOI: 10.1056/Nejm195102152440704  0.347
1950 JACKSON GG, GOCKE TM, COLLINS HS, FINLAND M. In vitro sensitivity of pathogenic enteric bacteria to various antibiotics. The Journal of Infectious Diseases. 87: 63-70. PMID 15437029 DOI: 10.1093/Infdis/87.1.63  0.528
1950 Finland M, Wilcox C. In Vitro Susceptibility of Hemophilus Influenzae to Seven Antibiotics: (Penicillin, Streptomycin, Bacitracin, Polymyxin, Aerosporin, Aureomycin and Chloromycetin) American Journal of Clinical Pathology. 20: 335-340. PMID 15432321 DOI: 10.1093/Ajcp/20.4.335  0.345
1950 Finland M, Frank PF, Wilcox C. In Vitro Susceptibility of Pathogenic Staphylococci to Seven Antibiotics: (Penicillin, Streptomycin, Bacitracin, Polymyxin, Aerosporin, Aureomycin and Chloromycetin) American Journal of Clinical Pathology. 20: 325-334. PMID 15432320 DOI: 10.1093/Ajcp/20.4.325  0.364
1950 JACKSON GG, GOCKE TM, WILCOX C, FINLAND M. In vitro susceptibility of pneumococci to seven antibiotics. American Journal of Clinical Pathology. 20: 218-24. PMID 15432301 DOI: 10.1093/Ajcp/20.3.218  0.551
1950 Finland M, Wilcox C, Frank PF. In Vitro Sensitivity of Human Pathogenic Strains of Streptococci to Seven Antibiotics: (Penicillin, Streptomycin, Bacitracin, Polymyxin, Aerosporin, Aureomycin and Chloromycetin) American Journal of Clinical Pathology. 20: 208-217. PMID 15432300 DOI: 10.1093/Ajcp/20.3.208  0.321
1950 WELLS EB, SHIH-MAN C, JACKSON GG, FINLAND M. Antibiotic spectrum of Hemophilus pertussis. The Journal of Pediatrics. 36: 752-7. PMID 15422491 DOI: 10.1016/S0022-3476(50)80230-5  0.515
1950 KASS EH, INGBAR SH, FINLAND M. Renal glycosuria induced by adrenocorticotrophic hormone. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 73: 669-72. PMID 15417635 DOI: 10.3181/00379727-73-17782  0.483
1950 Finland M, Wells EB, Collins HS, Gocke TM. Aureomycin in the treatment of influenza and certain other acute respiratory infections with or without pneumonia The American Journal of Medicine. 8: 21-30. PMID 15398848 DOI: 10.1016/0002-9343(50)90338-X  0.337
1950 Collins HS, Wells EB, Gocke TM, Finland M. Treatment of primary atypical pneumonia with aureomycin The American Journal of Medicine. 8: 4-20. PMID 15398847 DOI: 10.1016/0002-9343(50)90337-8  0.367
1950 KASS EH, LUNDGREN MM, FINLAND M. Failure of aureomycin and terramycin to increase resistance to toxic action of influenza virus. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 75: 520-3. PMID 14808312 DOI: 10.3181/00379727-75-18251  0.509
1950 JACKSON GG, BARNES MW, FINLAND M. Comparison of seven antibiotics against Hemophilus pertussis infection in chick embryos. Journal of Immunology (Baltimore, Md. : 1950). 65: 419-24. PMID 14794904  0.484
1950 JACKSON GG, CHANG SM, PLACE EH, FINLAND M. Sensitivity of diphtheria bacilli and related organisms to nine antibiotics. The Journal of Pediatrics. 37: 718-26. PMID 14784925 DOI: 10.1016/S0022-3476(50)80069-0  0.544
1950 JACKSON GG, SHIH-MAN C, BARNES MW, FINLAND M. Terramycin in pertussis: clinical and laboratory studies. Annals of the New York Academy of Sciences. 53: 422-6. PMID 14783351 DOI: 10.1111/J.1749-6632.1950.Tb42177.X  0.47
1950 KASS EH, BARNES MW, FINLAND M. Terramycin in influenza viral infections. Annals of the New York Academy of Sciences. 53: 412-21. PMID 14783350 DOI: 10.1111/J.1749-6632.1950.Tb42176.X  0.527
1950 GOCKE TM, JACKSON GG, WILCOX C, FINLAND M. In vitro studies on terramycin. Annals of the New York Academy of Sciences. 53: 297-302. PMID 14783338 DOI: 10.1111/J.1749-6632.1950.Tb42162.X  0.455
1950 FINLAND M, GOCKE TM, JACKSON GG, WOMACK CR, KASS EH. Clinical studies on terramycin. Annals of the New York Academy of Sciences. 53: 290-6. PMID 14783337 DOI: 10.1111/J.1749-6632.1950.Tb42161.X  0.588
1950 KASS EH, INGBAR SH, FINLAND M. Effects of adrenocorticotropic hormone in pneumonia: clinical, bacteriological and serological studies. Annals of Internal Medicine. 33: 1081-98. PMID 14783291 DOI: 10.7326/0003-4819-33-5-1081  0.488
1950 Gocke TM, Finland M. Development of chloramphenicol-resistant and chloramphenicol-dependent variants of a strain of Klebsiella pneumoniae. Experimental Biology and Medicine. 74: 824-829. PMID 14781193 DOI: 10.3181/00379727-74-18059  0.308
1950 KASS EH, FINLAND M. Effect of ACTH on induced fever. The New England Journal of Medicine. 243: 693-5. PMID 14780355 DOI: 10.1056/Nejm195011022431803  0.521
1950 WOMACK CR, KASS EH, FINLAND M. Further observations on a substance in egg yolk which protects aureomycin from deterioration. The Journal of Laboratory and Clinical Medicine. 36: 655-9. PMID 14779085  0.381
1950 Frank PF, Wilcox C, Finland M. In vitro sensitivity of Bacillus proteus and Pseudomonas aeruginosa to seven antibiotics; penicillin, streptomycin, bacitracin, polymyxin, aerosporin, aureomycin, and chloromycetin. Journal of Laboratory and Clinical Medicine. 35: 205-214. DOI: 10.5555/Uri:Pii:0022214350900746  0.35
1949 Collins HS, Finland M. Treatment of typhoid fever with chloromycetin; results in four cases and in a chronic carrier. The New England Journal of Medicine. 241: 556-561. PMID 18142743 DOI: 10.1056/Nejm194910132411502  0.352
1949 Finland M, Collins HS, Gocke TM, Wells EB. Present status of aureomycin therapy. Annals of Internal Medicine. 31: 39-52. PMID 18134809 DOI: 10.7326/0003-4819-31-1-39  0.35
1949 HARRIS HW, KILHAM L, FINLAND M. Local streptomycin therapy for suppurative otitis; bacteriologic and Archives of Otolaryngology. 49: 69-77. PMID 18110055 DOI: 10.1001/Archotol.1949.03760070076008  0.306
1949 Finland M, Collins HS, Wells EB. Aureomycin in the treatment of primary atypical pneumonia. The New England Journal of Medicine. 240: 241-246. PMID 18109605 DOI: 10.1056/Nejm194902172400701  0.323
1949 Finland M, Finnerty EF, Collins HS, Baird JW, Gocke TM, Kass EH. Aureomycin Treatment of Herpes Zoster The New England Journal of Medicine. 241: 1037-1047. PMID 15398246 DOI: 10.1056/Nejm194912292412602  0.553
1949 Collins HS, Gocke TM, Finland M. Aureomycin therapy of nonpneumococcic and nontuberculous bacterial pulmonary infections. Jama Internal Medicine. 84: 875-890. PMID 15397491 DOI: 10.1001/Archinte.1949.00230060032003  0.389
1949 Gocke TM, Collins HS, Finland M. AUREOMYCIN TREATMENT OF PNEUMOCOCCIC PNEUMONIA: Clinical and Laboratory Studies on Thirty-Three Patients Jama Internal Medicine. 84: 857-874. PMID 15397490 DOI: 10.1001/Archinte.1949.00230060014002  0.385
1948 Finland M, Jolliffe LS, Parker F. Pneumonia and erythema multiforme exudativum; report of four cases and three autopsies. The American Journal of Medicine. 4: 473-492. PMID 18909450 DOI: 10.1016/0002-9343(48)90435-5  0.334
1948 FINLAND M, COLLINS HS, PAINE TF. Aureomycin, a new antibiotic; results of laboratory studies and of clinical use in 100 cases of bacterial infections. Journal of the American Medical Association. 138: 946-9. PMID 18892416 DOI: 10.1001/Jama.1948.02900130010004  0.405
1948 Morgan HR, Neva FA, Fahey RJ, Finland M. Brill's disease; report of two serologically proved cases of typhus fever in Irish-born residents of Boston. The New England Journal of Medicine. 238: 871-873. PMID 18864482 DOI: 10.1056/Nejm194806172382503  0.3
1948 COLLINS HS, PAINE TF, FINLAND M. Aureomycin in treatment of pneumococcal pneumonia and meningococcemie. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 69: 263-5. PMID 18102197 DOI: 10.3181/00379727-69-16685  0.326
1947 Harris HW, Murray R, Paine TF, Kilham L, Finland M. Streptomycin treatment of urinary tract infections. With special reference to the use of alkali The American Journal of Medicine. 2: 229-250. PMID 20286818 DOI: 10.1016/0002-9343(47)90230-1  0.372
1946 Finland M, Murray R, Harris HW, Kilham L, Meads M, Wilcox C. Development of streptomycin resistance during treatment Journal of the American Medical Association. 132: 16-21. PMID 20995215 DOI: 10.1001/Jama.1946.02870360018005  0.385
1946 ORY EM, JACKSON GG, FINLAND M. Gram-negative bacillus empyema cured by intrapleural penicillin. Journal of the American Medical Association. 131: 1035-8. PMID 20991366 DOI: 10.1001/Jama.1946.02870300003002  0.499
1946 Murray R, Kilham L, Wilcox C, Finland M. Development of Streptomycin Resistance of Gram-Negative Bacilli In vitro and During Treatment. Experimental Biology and Medicine. 63: 470-474. PMID 20277789 DOI: 10.3181/00379727-63-15640  0.323
1946 Ory EM, Harris HW, Meads M, Wilcox C, Finland M. Bacteriologic studies of the sputum in patients with pneumococcal pneumonia treated with penicillin. Journal of Laboratory and Clinical Medicine. 31: 409-422. DOI: 10.5555/Uri:Pii:0022214346902053  0.35
1945 Homburger F, Wilcox C, Barnes MW, Finland M. AN EPIZOOTIC OF PNEUMOCOCCUS TYPE 19 INFECTIONS IN GUINEA PIGS. Science (New York, N.Y.). 102: 449-50. PMID 17733184 DOI: 10.1126/Science.102.2653.449  0.316
1945 Finland M, Parker F, Barnes MW, Joliffe LS. ACUTE MYOCARDITIS IN INFLUENZA A INFECTIONS: Two Cases of Non-bacterial Myocarditis, With Isolation of Virus From the Lungs The American Journal of the Medical Sciences. 209: 455-468. DOI: 10.1097/00000441-194504000-00005  0.329
1945 Meads M, Harris HW, Finland M. The Treatment of Bacterial Endocarditis with Penicillin The New England Journal of Medicine. 232: 463-474. DOI: 10.1056/Nejm194504262321701  0.339
1945 Meads M, Flipse ME, Barnes MW, Finland M, Drew R, Northrop A. Penicillin treatment of scarlet fever: Bacteriologic study of the nose and throat of patients treated intramuscularly or by spray with penicillin and a comparison with sulfadiazine Journal of the American Medical Association. 129: 785-789. DOI: 10.1001/Jama.1945.02860460009002  0.385
1944 Smith HW, Thomas L, Dingle JH, Finland M. Meningococcic Infections; Report Of 43 Cases Of Meningococcic Meningitis And 8 Cases Of Meningococcemia* Annals of Internal Medicine. 20: 12-32. DOI: 10.7326/0003-4819-20-1-12  0.713
1942 Finland M, Peterson OL, Goodwin RA. Sulfadiazine; Further Clinical Studies Of Its Efficacy And Toxic Effects In 460 Patients Annals of Internal Medicine. 17: 920-934. DOI: 10.7326/0003-4819-17-6-920  0.339
1942 Dingle JH, Finland M. Virus Pneumonias New England Journal of Medicine. 227: 378-385. DOI: 10.1056/Nejm194209032271004  0.691
1942 Finland M, Dingle JH. Virus Pneumonias New England Journal of Medicine. 227: 342-350. DOI: 10.1056/Nejm194208272270905  0.691
1941 Strauss E, Dingle JH, Finland M. Use of Para-Aminobenzoic Acid to Inhibit Sulfonamide Action in Bactericidal Tests Experimental Biology and Medicine. 46: 131-133. DOI: 10.3181/00379727-46-11911  0.682
1941 Finland M, Dingle JH. Treatment of Meningitis New England Journal of Medicine. 225: 825-832. DOI: 10.1056/Nejm194111202252105  0.682
1941 Finland M, Strauss E, Peterson OL. Sulfadiazine: Therapeutic Evaluation and Toxic Effects on Four Hundred and Forty-six Patients Jama. 116: 1467-1474. DOI: 10.1001/Jama.1941.02820240001001  0.346
1940 Finland M, Spring WC, Lowell FC. Specific Treatment Of The Pneumococcic Pneumonias; An Analysis Of The Results Of Serum Therapy And Chemotherapy At The Boston City Hospital From July 1938 Through June 1939 Annals of Internal Medicine. 13: 1567-1593. DOI: 10.7326/0003-4819-13-9-1567  0.338
1940 Finland M, Lowell FC, Spring WC. Clinical and Laboratory Studies on the Use of Serum and Sulfapyridine in the Treatment of the Pneumococcal Pneumonias The New England Journal of Medicine. 222: 739-747. DOI: 10.1056/Nejm194005022221801  0.303
1939 Brown JW, Finland M. A Family Outbreak Of Type V Pneumococcic Infections: Clinical, Bacteriological And Immunological Studies Annals of Internal Medicine. 13: 394-401. DOI: 10.7326/0003-4819-13-3-394  0.312
1939 Finland M. The Use of Serum, Sulfanilamide, and Sulfapyridine in the Treatment of Pneumococcic Infections Medical Clinics of North America. 23: 1205-1219. DOI: 10.1016/S0025-7125(16)36813-4  0.334
1937 Finland M, Ruegsegger JM, Dowling HF, Tilgilman RC. Infections With Pneumococcus Type Vii The American Journal of the Medical Sciences. 193: 48-58. DOI: 10.1097/00000441-193701000-00008  0.312
1937 Finland M. Some Aspects of Pneumococcus Infection in Man The New England Journal of Medicine. 216: 460-461. DOI: 10.1056/Nejm193703182161107  0.324
1936 Finland M, Dowling HF. Pneumococcus Type Ii And Type V Infections Jama Internal Medicine. 58: 598-619. DOI: 10.1001/Archinte.1936.00170140023003  0.301
1934 SUTLIFF WD, FINLAND M. Type I Pneumococcic Infections with Especial Reference to Specific Serum Treatment New England Journal of Medicine. 210: 237-245. DOI: 10.1056/Nejm193402012100501  0.335
1934 Finland M. The Significance Of Mixed Infections In Pneumococcic Pneumonia Jama. 103: 1681-1686. DOI: 10.1001/Jama.1934.02750480019005  0.357
1934 FINLAND M. INFECTIONS WITH PNEUMOCOCCUS TYPE III AND TYPE VIII Archives of Internal Medicine. 53: 481. DOI: 10.1001/Archinte.1934.00160100003001  0.307
1933 FINLAND M. THE SPECIFIC SERUM TREATMENT OF PNEUMOCOCCUS TYPE II PNEUMONIA Jama: the Journal of the American Medical Association. 100: 560. DOI: 10.1001/Jama.1933.02740080024006  0.301
1931 Sutliff WD, Finland M. Type I Lobar Pneumonia Treated With Concentrated Pneumococcic Antibody (Felton): The Clinical Course Jama. 96: 1465-1469. DOI: 10.1001/Jama.1931.02720440013004  0.305
1930 Robey WH, Finland M. Effect of Tonsillectomy on the Acute Attack of Rheumatic Fever. Preliminary Report. Jama Internal Medicine. 45: 772-782. DOI: 10.1001/Archinte.1930.00140110128011  0.321
Show low-probability matches.